Another HIV Vaccine Trial Canceled Due to Poor Results
WEDNESDAY, Sept. 1, 2021 (HealthDay News) — Another trial of an experimental HIV vaccine has been halted after researchers concluded the vaccine provided only limited protection. The trial in five sub-Saharan African countries was launched in 2017 to assess the Johnson & Johnson HIV vaccine in over 2,000 young womenContinue Reading